Halozyme Therapeutics
HALO
#2061
Rank
A$12.02 B
Marketcap
$97.67
Share price
-0.09%
Change (1 day)
57.04%
Change (1 year)

Halozyme Therapeutics (HALO) - Net assets

Net assets on the balance sheet as of December 2024 : A$0.57 Billion

According to Halozyme Therapeutics's latest financial reports the company has A$0.57 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Halozyme Therapeutics - Net assets on balance sheet (from 2002 to 2024)

Net assets by year

Year Net assets Change
2024-12-31$A$0.58 B375.5%
2023-12-31$A$0.12 B-50.7%
2022-12-31$A$0.24 B-8.15%
2021-12-31$A$0.27 B38.3%
2020-12-31$A$0.19 B49.88%
2019-12-31$A$0.13 B-62.9%
2018-12-31$A$0.35 B32.37%
2017-12-31$A$0.26 B-692.3%
2016-12-31$-A$45.07 Million-176.34%
2015-12-31$A$59.02 M16.82%
2014-12-31$A$50.52 M-325.46%
2013-12-31$-A$22.42 Million-147.67%
2012-12-31$A$47.01 M342.22%
2011-12-31$A$10.63 M-46.94%
2010-12-31$A$20.03 M160.71%
2009-12-31$A$7.68 M-64.75%
2008-12-31$A$21.79 M-67.01%
2007-12-31$A$66.07 M125.67%
2006-12-31$A$29.27 M17.67%
2005-12-31$A$24.88 M29.89%
2004-12-31$A$19.15 M3709.19%
2003-12-31$A$0.5 M-174.65%
2002-12-31$-A$0.68 Million-1605.48%
2001-12-31$A$0.04 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
-A$0.13 Billion-121.66%๐Ÿ‡บ๐Ÿ‡ธ USA
A$22.70 B 3,822.70%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.17 B 1,830.62%๐Ÿ‡บ๐Ÿ‡ธ USA
A$140.81 B 24,224.32%๐Ÿ‡บ๐Ÿ‡ธ USA
A$128.91 B 22,168.97%๐Ÿ‡ซ๐Ÿ‡ท France
A$113.75 B 19,549.77%๐Ÿ‡บ๐Ÿ‡ธ USA